EGIS-7229, the new combined class III antiarrhythmic agent Lack of EAD inducing effect - rationale, design, and methods (the SWORD trial)

Author： Banyasz T.   Magyar J.   Varro A.   Kovacs A.   Gyonos I.   Szenasi G.   Nanasi P.P.  

Publisher： Elsevier

ISSN： 0306-3623

Source： General Pharmacology, Vol.32, Iss.3, 1999-03, pp. : 329-333

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Electrophysiological Effects of EGIS-7229, a New Antiarrhythmic Agent, in Isolated Guinea Pig Papillary Muscle

By Pankucsi C.   Banyasz T.   Magyar J.   Gyonos I.   Kovacs A.   Szenasi G.   Varro A.   Nanasi P.P.  

General Pharmacology, Vol. 29, Iss. 2, 1997-08 ,pp. : 275-280

Elsevier

Access to resources Recommend Favorite

Azimilide dihydrochloride: a new class III anti-arrhythmic agent

By Abrol R.   Page R.L.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 11, 2000-11 ,pp. : 2705-2715

Informa Healthcare

Access to resources Recommend Favorite

Treatment of Atrial Fibrillation and Flutter: Focus on Oral Dofetilide, a New Selective Class III Antiarrhythmic Agent

By  

Heart Drug, Vol. 1, Iss. 6, 2002-02 ,pp. : 320-331

Karger

Access to resources Recommend Favorite

Novel Antiarrhythmic Compounds with Combined Class IB and Class III Mode of Action

By  

Current Medicinal Chemistry, Vol. 11, Iss. 1, 2004-01 ,pp. : 61-69

Bentham Science Publishers

Access to resources Recommend Favorite

3,8-Diazabicyclo-[3.2.1]-octane derivatives as analogues of ambasilide, a Class III antiarrhythmic agent

By Villa S.   Barlocco D.   Cignarella G.   Papp G.J.   Balati B.   Takacs J.   Varro A.   Borosy A.   Keseru K.   Matyus P.  

European Journal of Medicinal Chemistry, Vol. 36, Iss. 6, 2001-06 ,pp. : 495-506

Elsevier

Access to resources Recommend Favorite